Mexico City, Mexico.
We are looking for a Pharmacoeconomics RWE Manager who has the ability to work multifunctionally, in a team, good communication skills, assertive communication, leadership, work under pressure, enabling effective collaboration with diverse stakeholders to join us in our team, based in CDMX.
About the role:
Leads, develops and implements pharmacoeconomic analyzes and strategies for the entire UCB portfolio, aligned with the PVU objective. Implement strategies to set the prices in public and private markets, start RWE projects with the KDM’s / KOL’s.
Who you’ll work with:
Internal & external stakeholders
What you’ll do:
Leads in the daily business operations of Access and works very close to PVUs as a strong business partner to generate value for the affiliate specialized in access and value projects supported in pharmacoeconomic topics.
Develops, implements, and provides technical information with key messages to allow access for the UCB portfolio.
Responsible for the planning, conducting and final review stages of economic evaluation studies in the therapeutic areas UCB scope.
Provide, optimize, and lead key and robust information about the economic impact of the use of UCB Solutions among communities of decision makers, opinion leaders, health care professionals, and patients.
Ensures UCB Operational Compliance to the highest professional standards. The expectation is that compliance is a part of how we operate within the new Ecosystem Team environment. Adherence to compliant behavior is an expectation at UCB.
Interested? For this role we’re looking for the following education, experience and skills
Bachelor’s degree in Medicine, health economics and related
Advanced English (HTA, overall language proficiency)
Experience in Pharmacoeconomics, Health Economics, HEOR manager, RWE
Excel, Power Point, Word, CMR Management
Desirable: knowledge of pharmacoeconomics approach for orphan drugs.
This job is posted by UCB.
This link brings you to the website of UCB.
Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!
